This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays

Savings Deadline Ends In:

  • 00
  • 00
  • 00
  • 00
November 1-3, 2022
College Park Marriott Hotel & Conference CenterHyattsville, Maryland, USA

Lynne Frick
CEO at Cell X Technologies


Lynne Frick is CEO of Cell X Technologies, Inc, a Cleveland Clinic spin out with a platform to automate and manage stem cell workflows, including differentiation and expansion tracked by GMP compliant data management software and integrated with analytical results. Most recently, she was CEO of 4th Dimension Bioprocess, Inc., a CDMO focused on innovation and operational efficiency in Continuous Bioprocessing, which was sold to Resilience, Inc. in Dec 2020, where she then served as Co-Head of the Biologics Franchise. She has extensive experience with start-ups and emerging Life Sciences technology and service companies, leading them from inception to sale.

Agenda Sessions

  • Starting Material Selection in iPS-Derived Cardiomyocytes